Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Bruker Corporation BRKR
$74.05
-$2.43 (-3.28%)
На 18:00, 12 мая 2023
-18.97%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
11145687368.00000000
-
week52high
84.84
-
week52low
48.42
-
Revenue
2530700000
-
P/E TTM
39
-
Beta
1.15432500
-
EPS
1.99000000
-
Last Dividend
0.20000000
-
Next Earnings Date
04 мая 2023 г. в 12:30
Описание компании
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Citigroup | Buy | Neutral | 22 авг 2022 г. |
SVB Leerink | Outperform | Outperform | 05 мая 2022 г. |
Goldman Sachs | Sell | Sell | 13 апр 2022 г. |
SVB Leerink | Outperform | Outperform | 14 февр 2022 г. |
Wells Fargo | Equal-Weight | Equal-Weight | 02 ноя 2021 г. |
UBS | Buy | 21 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Friend Cynthia M | D | 11576 | 921 | 17 янв 2023 г. |
Ma Philip | A | 3586 | 1970 | 05 янв 2023 г. |
Anderson Bonnie H | A | 7652 | 1970 | 05 янв 2023 г. |
LINTON WILLIAM A | A | 23048 | 1970 | 05 янв 2023 г. |
Kastner Marc A | A | 20021 | 1970 | 05 янв 2023 г. |
ROSENTHAL BOB | A | 20770 | 1970 | 05 янв 2023 г. |
PACKER RICHARD A | A | 71877 | 1970 | 05 янв 2023 г. |
Perkins Adelene Q | A | 18949 | 1970 | 05 янв 2023 г. |
Friend Cynthia M | A | 12497 | 1970 | 05 янв 2023 г. |
Requardt Hermann Fritz | A | 20770 | 1970 | 05 янв 2023 г. |
Новостная лента
Bruker's (BRKR) New Buyout to Advance Digital Transformation
Zacks Investment Research
09 мая 2023 г. в 11:27
Bruker's (BRKR) IDS division expands its unique vendor-agnostic software solutions portfolio by integrating ZONTAL with the Mestrelab Research and Arxspan scientific software solutions.
Bruker Corporation (BRKR) Q1 2023 Earnings Call Transcript
Seeking Alpha
06 мая 2023 г. в 12:08
Bruker Corporation (NASDAQ:BRKR ) Q1 2023 Earnings Conference Call May 4, 2023 8:30 AM ET Company Participants Justin Ward - Senior Director of IR & Corporate Development Frank Laukien - Chairman, President & CEO Gerald Herman - EVP & CFO Conference Call Participants John Sourbeer - UBS Puneet Souda - SVB Securities Josh Waldman - Cleveland Research Daniel Arias - Stifel Patrick Donnelly - Citi Rachel Vatnsdal - JPMorgan Jack Meehan - Nephron Daniel Brennan - Cowen Brandon Couillard - Jefferies Matt Sykes - Goldman Sachs Operator Good day, and welcome to the Bruker Corporation First Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode.
Bruker (BRKR) Tops Q1 Earnings Estimates, Raises '23 Outlook
Zacks Investment Research
05 мая 2023 г. в 09:09
Bruker (BRKR) delivers a year-over-year revenue increase across all its segments in the first quarter, led by the strong demand for differentiated, high-performance scientific instruments and life-science solutions.
Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast
Business Wire
26 апр 2023 г. в 16:05
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2023 financial results before market opening on Thursday, May 4, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q1 2023 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide presentat.
Why Bruker (BRKR) is a Top Growth Stock for the Long-Term
Zacks Investment Research
21 апр 2023 г. в 11:25
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.